Skip to content
Home/Companies/Healthcare/XERIS Pharmaceuticals
XP

XERIS Pharmaceuticals

Healthcare·US·Exited 2018·Held 1yr

XERIS Pharmaceuticals is a healthcare company, headquartered in US.

Entry
2017
Hold
1yr
Exit
2018
Est. EV
–

Who owns XERIS Pharmaceuticals?

XERIS Pharmaceuticals was owned by Merieux Equity Partners through Mérieux Innovation 1 (2014 vintage) from 2017 to 2018, exited via IPO.

Buyer identity available on Pro.

Hand-verified · updated 2026-05-07

Merieux Equity Partners
Investor
Merieux Equity Partners
Mérieux Innovation 1 · 2014 · VC

Key facts

HQUS
SectorHealthcare
StatusAcquired
Exit Type
IPO
Buyer
MOIC
–
Exit Year
2018

More from Mérieux Innovation 1

Other portfolio companies in the same fund.

Broken String Biosciences
Active
HealthcareEurope· 2023
InnoSyn
Active
HealthcareEurope· 2023
LabQuality
Exited 2025
HealthcareEurope· 2023
to
Cairdac
Active
HealthcareEurope· 2022
Mablink Bioscience
Exited 2023
HealthcareEurope· 2022
to
SeqOne Genomics
Active
HealthcareEurope· 2022

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
Active
Advent InternationalUS
Data refreshed weekly · Sourced from public filings